Equity Profile

LMAT

LeMaitre Vascular, Inc.

Health CareHealth Care Equipment$1.9B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, specifically focusing on medical devices for vascular surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

$0.70

Revenue

Revenue growth reflects the company's ability to increase sales and market share, which is crucial for long-term success.

$68M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LMAT Q2-2026 Earnings Preview

Context

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, specifically focusing on medical devices for vascular surgery. The company is important as it provides specialized equipment that can improve patient outcomes in vascular procedures, a growing area in health care.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q1-2026, LeMaitre reported an EPS of $0.68, exceeding expectations by 2.56%. The stock reacted positively, gaining 0.42% the following day.

Management Promises & Guidance

Continue to innovate in vascular surgery products.
Expand market reach in international territories.
Focus on improving operational efficiency.

Expectations

Wall Street Expectations

Analysts expect LeMaitre to report solid earnings with a consensus EPS of $0.70 and revenue of $68M. The company has a history of beating EPS estimates, which could lead to positive market reactions.

Bull Case

If LeMaitre exceeds EPS and revenue expectations, it could signal strong demand for its products and potentially lead to a stock price increase.

Bear Case

Conversely, if the company misses its targets, it could raise concerns about sales growth and market competition, leading to a decline in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.70

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$68M

Revenue growth reflects the company's ability to increase sales and market share, which is crucial for long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $0.70, and by how much?

A strong EPS could reinforce investor confidence and suggest robust demand for LeMaitre's products.

What is the revenue outlook for the next quarter?

Revenue guidance will be critical to assess the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate LeMaitre's ability to innovate and capture market share, especially given its recent product launches.

Supporting Evidence

LeMaitre has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

The options market is pricing in a larger move than historical averages, suggesting potential for a significant reaction.

Management's focus on international expansion could provide unexpected revenue boosts.

Key Risk

If the revenue exceeds $70M, it could challenge the current bearish sentiment and validate the company's growth strategy.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will reflect the company's ability to maintain growth in a competitive health care equipment market.

Bull Confirmed If

An EPS of $0.75 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.68 would indicate potential challenges in sales or market competition.

Pre-Earnings Positioning

Options Market

Implied Move

±3.08%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a move of about 3.08%, indicating some uncertainty around the earnings report.

Options are pricing ±3.1% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.4%

Calls (0)P/C Ratio: 12.00Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests the stock could rise by around 0.06% on average the next day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further commentary from management.

Miss

If the company misses its targets, historical patterns indicate a potential decline of about 1.80% the following day, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on international sales growth and market expansion efforts.
2Details on new product launches and their reception in the market.
3Management's commentary on cost management and operational efficiency.
4Insights into competitive pressures in the vascular surgery market.
5Guidance on revenue expectations for the upcoming quarter.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, specifically focusing on medical devices for vascular surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

$0.70

Revenue

Revenue growth reflects the company's ability to increase sales and market share, which is crucial for long-term success.

$68M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LMAT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q1-2026, LeMaitre reported an EPS of $0.68, exceeding expectations by 2.56%. The stock reacted positively, gaining 0.42% the following day.

Management Promises & Guidance

Continue to innovate in vascular surgery products.
Expand market reach in international territories.
Focus on improving operational efficiency.

Expectations

Wall Street Expectations

Analysts expect LeMaitre to report solid earnings with a consensus EPS of $0.70 and revenue of $68M. The company has a history of beating EPS estimates, which could lead to positive market reactions.

Bull Case

If LeMaitre exceeds EPS and revenue expectations, it could signal strong demand for its products and potentially lead to a stock price increase.

Bear Case

Conversely, if the company misses its targets, it could raise concerns about sales growth and market competition, leading to a decline in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.70

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$68M

Revenue growth reflects the company's ability to increase sales and market share, which is crucial for long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $0.70, and by how much?

A strong EPS could reinforce investor confidence and suggest robust demand for LeMaitre's products.

What is the revenue outlook for the next quarter?

Revenue guidance will be critical to assess the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate LeMaitre's ability to innovate and capture market share, especially given its recent product launches.

Supporting Evidence

LeMaitre has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

The options market is pricing in a larger move than historical averages, suggesting potential for a significant reaction.

Management's focus on international expansion could provide unexpected revenue boosts.

Key Risk

If the revenue exceeds $70M, it could challenge the current bearish sentiment and validate the company's growth strategy.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will reflect the company's ability to maintain growth in a competitive health care equipment market.

Bull Confirmed If

An EPS of $0.75 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.68 would indicate potential challenges in sales or market competition.

Pre-Earnings Positioning

Options Market

Implied Move

±3.08%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a move of about 3.08%, indicating some uncertainty around the earnings report.

Options are pricing ±3.1% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.4%

Calls (0)P/C Ratio: 12.00Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests the stock could rise by around 0.06% on average the next day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further commentary from management.

Miss

If the company misses its targets, historical patterns indicate a potential decline of about 1.80% the following day, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on international sales growth and market expansion efforts.
2Details on new product launches and their reception in the market.
3Management's commentary on cost management and operational efficiency.
4Insights into competitive pressures in the vascular surgery market.
5Guidance on revenue expectations for the upcoming quarter.